The national GeneMatch program uses genetic testing information to recruit participants for Alzheimer’s prevention studies. Under the agreement, Vantari Genetics and Translational Software will genotype volunteers interested in community-based research opportunities to help the institute select which participants are most appropriate for various studies.
The Banner Alzheimer’s Institute, a program of Banner Health, will also analyze genomic and molecular data from genotype tests to understand the genetic variants of volunteers, including their genetic risk for developing Alzheimer’s.
More articles on data analytics & precision medicine:
KLAS: 14% of providers report ‘deep interoperability’ among disparate EMRs
Cleveland Clinic’s Medical Innovation Summit to tackle precision medicine
AMA partners with Cerner, IBM to develop common data model
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.